OstomyCure

Oslo, Norway Founded: 2004 • Age: 22 yrs
Develops innovative stoma management solutions for ileostomy patients through clinical trials.

About OstomyCure

OstomyCure is a company based in Oslo (Norway) founded in 2004. It operates as a B2B and D2C. OstomyCure offers products and services including TIES Implant, TIES Lid, TIES Emptying Pouch, and TIES System. OstomyCure operates in a competitive market with competitors including Axonics, Averto Medical, Boomerang Medical, Signum Surgical and NovoGI, among others.

Key Metrics

Products & Services of OstomyCure

OstomyCure offers a comprehensive portfolio of products and services, including TIES Implant, TIES Lid, TIES Emptying Pouch, and TIES System.

TIES Implant
Medical Device

Implant for ileostomy patients to manage stoma output effectively.

TIES Lid
Accessory Device

Seals the implant to prevent leakage and enhance user control.

TIES Emptying Pouch
Supportive Tool

Pouch for emptying intestinal waste from the TIES system.

TIES System
Comprehensive Solution

Integrated system for stoma management in daily life.

Apps and channels of OstomyCure

its YouTube channel OstomyCure has 8 subscribers.

OstomyCure
YouTube 8 subscribers
Open channel

Funding Insights of OstomyCure

  • Total Rounds 1
  • Last Round Grant — $2.2M
  • First Round $2.2M

    (Jan 2019)

  • Investors Count 1

All 1 funding rounds of OstomyCure with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2019$2.2MGrant––
Valuation history

1 investors in total: 1 institutional.

Investors in OstomyCure

OstomyCure has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for OstomyCure

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of OstomyCure

2 dated milestones of OstomyCure across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded OstomyCure is founded.
  2. Funding First funding round of $2.2M.

Competitors of OstomyCure

OstomyCure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Axonics, Averto Medical, Boomerang Medical, Signum Surgical and NovoGI, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
axonics.com2013Irvine, United States$143.47M762
Sacral neuromodulation devices are developed for urinary and bowel control.
avertomed.com2016Fremont, United States$33M18
Medical devices for gastrointestinal disease patients are developed.
boomerangmedical.com2021Mountain View, United States$35M–
Bioelectronic devices are developed for autoimmune disease treatment.
signumsurgical.com2014Galway, Ireland$5.73M–
Surgically implanted devices for perianal fistula treatment are provided.
novogi.com1996Netanya, Israel$18.5M–
Provides compression anastomosis devices for GI disease management.
mowoot.com2014Barcelona, Spain$3.98M–
A non-invasive medical device for chronic constipation treatment is developed.
spirusmedllc.com2005West Bridgewater, United States$15.24M–
Spiral over-tubes and steerable introducers for GI endoscopy are provided.
exeromedical.com2018Or Yehuda, Israel$10M–
Develoepr of a sensor device for early detection of anastomotic leaks
tytex.com1996Ikast, Denmark–583
Specialized apparels for continence, post-surgery, and wound care are produced.
colospan.com2010Kfar Saba, Israel$8M–
Intraluminal bypass devices are developed to reduce colorectal surgery complications.
Premium access

Detailed competitors of OstomyCure

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ostomycure

Premium access

Complete news archive for OstomyCure

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to OstomyCure

10 companies that operate in the same segment as OstomyCure (Diversified Medical Devices), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medical equipment for treating over 30 chronic diseases is developed.
1949Minneapolis, Minnesota, United States–USD 36.36 B95,000
Wide range of medical devices
1979Marlborough, Massachusetts, United States–USD 20.07 B53,000
Healthcare solutions are provided by Johnson & Johnson globally.
1886New Brunswick, New Jersey, United States–USD 94.18 B139,800
Diagnostic and surgical products for women's healthcare are provided.
1985Marlborough, Massachusetts, United States–USD 4.1 B7,060
Developer of drug candidates for the treatment of rare CNS disorders
1971Boston, Massachusetts, United StatesUSD 105.8 M–487
Surgical instruments are manufactured for multiple therapeutic areas.
1987Utica, New York, United States–USD 1.37 B3,900
A wide range of medical devices is developed by HOYA.
1941Tokyo, Tokyo, Japan–USD 5.94 B37,910
Medical devices for cardiac and neuromodulation therapies are manufactured globally.
1976Saint Paul, Minnesota, United States–––
Complex healthcare challenges are addressed through technology solutions by Commure.
2016San Francisco, California, United StatesUSD 823.3 M–316
Provider of medical devices for emergency medicine and various health conditions
1943Wayne, United States–USD 1.99 B14,100
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about OstomyCure

OstomyCure was founded in 2004 and raised its 1st funding round 15 years after it was founded.

OstomyCure is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.

OstomyCure AS is a medical technology company based in Oslo, Norway, that creates the TIES Solution, an implant system for ileostomy patients. It includes the TIES Implant, Lid, and Emptying Pouch to provide controlled stoma management, reducing the need for traditional ostomy bags. The company conducts clinical trials in various countries like the UK and Sweden, aiming to enhance patient comfort and quality of life while adhering to regulatory standards. It collaborates with clinics and focuses on innovative healthcare advancements.

OstomyCure's top competitors include Axonics, Signum Surgical and Exero Medical.

OstomyCure offers TIES Implant, TIES Lid, TIES Emptying Pouch, and TIES System.

OstomyCure has 1 investor. Key investors include European Union.

OstomyCure operates through Ostomycure As.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available